 | • レポートコード：QYR9ST04095 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、アルコール性肝炎治療薬の世界市場について調査・分析し、アルコール性肝炎治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、蛋白同化ステロイド、肝刺激ホルモン、スルフヒドリル剤、その他）、用途別（病院および診療所、研究開発）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアルコール性肝炎治療薬市場動向 ・主要企業別マーケットシェア ・アルコール性肝炎治療薬の種類別市場規模2014-2019 （モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、蛋白同化ステロイド、肝刺激ホルモン、スルフヒドリル剤、その他） ・アルコール性肝炎治療薬の用途別市場規模2014-2019 （病院および診療所、研究開発） ・アルコール性肝炎治療薬の北米市場：主要企業・種類別/用途別市場規模 ・アルコール性肝炎治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・アルコール性肝炎治療薬の中国市場：主要企業・種類別/用途別市場規模 ・アルコール性肝炎治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・アルコール性肝炎治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・アルコール性肝炎治療薬のインド市場：主要企業・種類別/用途別市場規模 ・アルコール性肝炎治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Alkermes、Conatus pharmaceuticals、Dainippon sumitomo pharma、Generon corporation、Immuron limited、Lupin Laboratories、Intercept Pharmaceuticals、Teva Pharmaceuticals、Sanofi-Aventis） ・アルコール性肝炎治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
In 2018, the global Alcoholic Hepatitis Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Alcoholic Hepatitis Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alcoholic Hepatitis Therapeutic development in United States, Europe and China.
The key players covered in this study
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Market segment by Type, the product can be split into
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Market segment by Application, split into
Hospitals and Clinics
Research and Development
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Alcoholic Hepatitis Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Alcoholic Hepatitis Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Alcoholic Hepatitis Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Caspase Protease Inhibitor
1.4.4 Corticosteroids
1.4.5 Hemorheologic Agents
1.4.6 Anabolic Steroids
1.4.7 Hepatotropic Hormones
1.4.8 Sulfhydryl Agents
1.4.9 Others
1.5 Market by Application
1.5.1 Global Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Research and Development
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Alcoholic Hepatitis Therapeutic Market Size
2.2 Alcoholic Hepatitis Therapeutic Growth Trends by Regions
2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Regions (2014-2025)
2.2.2 Alcoholic Hepatitis Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Alcoholic Hepatitis Therapeutic Market Size by Manufacturers
3.1.1 Global Alcoholic Hepatitis Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Alcoholic Hepatitis Therapeutic Key Players Head office and Area Served
3.3 Key Players Alcoholic Hepatitis Therapeutic Product/Solution/Service
3.4 Date of Enter into Alcoholic Hepatitis Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019)
4.2 Global Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019)
5 United States
5.1 United States Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
5.2 Alcoholic Hepatitis Therapeutic Key Players in United States
5.3 United States Alcoholic Hepatitis Therapeutic Market Size by Type
5.4 United States Alcoholic Hepatitis Therapeutic Market Size by Application
6 Europe
6.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
6.2 Alcoholic Hepatitis Therapeutic Key Players in Europe
6.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Type
6.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Application
7 China
7.1 China Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
7.2 Alcoholic Hepatitis Therapeutic Key Players in China
7.3 China Alcoholic Hepatitis Therapeutic Market Size by Type
7.4 China Alcoholic Hepatitis Therapeutic Market Size by Application
8 Japan
8.1 Japan Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
8.2 Alcoholic Hepatitis Therapeutic Key Players in Japan
8.3 Japan Alcoholic Hepatitis Therapeutic Market Size by Type
8.4 Japan Alcoholic Hepatitis Therapeutic Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
9.2 Alcoholic Hepatitis Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Type
9.4 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Application
10 India
10.1 India Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
10.2 Alcoholic Hepatitis Therapeutic Key Players in India
10.3 India Alcoholic Hepatitis Therapeutic Market Size by Type
10.4 India Alcoholic Hepatitis Therapeutic Market Size by Application
11 Central & South America
11.1 Central & South America Alcoholic Hepatitis Therapeutic Market Size (2014-2019)
11.2 Alcoholic Hepatitis Therapeutic Key Players in Central & South America
11.3 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Type
11.4 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Application
12 International Players Profiles
12.1 Alkermes
12.1.1 Alkermes Company Details
12.1.2 Company Description and Business Overview
12.1.3 Alcoholic Hepatitis Therapeutic Introduction
12.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.1.5 Alkermes Recent Development
12.2 Conatus pharmaceuticals
12.2.1 Conatus pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Alcoholic Hepatitis Therapeutic Introduction
12.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.2.5 Conatus pharmaceuticals Recent Development
12.3 Dainippon sumitomo pharma
12.3.1 Dainippon sumitomo pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Alcoholic Hepatitis Therapeutic Introduction
12.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.3.5 Dainippon sumitomo pharma Recent Development
12.4 Generon corporation
12.4.1 Generon corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Alcoholic Hepatitis Therapeutic Introduction
12.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.4.5 Generon corporation Recent Development
12.5 Immuron limited
12.5.1 Immuron limited Company Details
12.5.2 Company Description and Business Overview
12.5.3 Alcoholic Hepatitis Therapeutic Introduction
12.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.5.5 Immuron limited Recent Development
12.6 Lupin Laboratories
12.6.1 Lupin Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Alcoholic Hepatitis Therapeutic Introduction
12.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.6.5 Lupin Laboratories Recent Development
12.7 Intercept Pharmaceuticals
12.7.1 Intercept Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Alcoholic Hepatitis Therapeutic Introduction
12.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.7.5 Intercept Pharmaceuticals Recent Development
12.8 Teva Pharmaceuticals
12.8.1 Teva Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Alcoholic Hepatitis Therapeutic Introduction
12.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.8.5 Teva Pharmaceuticals Recent Development
12.9 Sanofi-Aventis
12.9.1 Sanofi-Aventis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Alcoholic Hepatitis Therapeutic Introduction
12.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)
12.9.5 Sanofi-Aventis Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Alcoholic Hepatitis Therapeutic Key Market Segments
Table Key Players Alcoholic Hepatitis Therapeutic Covered
Table Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Caspase Protease Inhibitor Figures
Table Key Players of Caspase Protease Inhibitor
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Hemorheologic Agents Figures
Table Key Players of Hemorheologic Agents
Figure Anabolic Steroids Figures
Table Key Players of Anabolic Steroids
Figure Hepatotropic Hormones Figures
Table Key Players of Hepatotropic Hormones
Figure Sulfhydryl Agents Figures
Table Key Players of Sulfhydryl Agents
Figure Others Figures
Table Key Players of Others
Table Global Alcoholic Hepatitis Therapeutic Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Research and Development Case Studies
Figure Alcoholic Hepatitis Therapeutic Report Years Considered
Table Global Alcoholic Hepatitis Therapeutic Market Size 2014-2025 (Million US$)
Figure Global Alcoholic Hepatitis Therapeutic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alcoholic Hepatitis Therapeutic Market Size by Regions 2014-2025 (Million US$)
Table Global Alcoholic Hepatitis Therapeutic Market Size by Regions 2014-2019 (Million US$)
Table Global Alcoholic Hepatitis Therapeutic Market Share by Regions 2014-2019
Figure Global Alcoholic Hepatitis Therapeutic Market Share by Regions 2014-2019
Figure Global Alcoholic Hepatitis Therapeutic Market Share by Regions 2019
Table Market Top Trends
Table Global Alcoholic Hepatitis Therapeutic Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Alcoholic Hepatitis Therapeutic Market Share by Manufacturers (2014-2019)
Figure Global Alcoholic Hepatitis Therapeutic Market Share by Manufacturers in 2018
Table Global Alcoholic Hepatitis Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alcoholic Hepatitis Therapeutic Product/Solution/Service
Table Date of Enter into Alcoholic Hepatitis Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Global Alcoholic Hepatitis Therapeutic Market Size Share by Type (2014-2019)
Figure Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Type (2014-2019)
Table Global Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Global Alcoholic Hepatitis Therapeutic Market Size Share by Application (2014-2019)
Figure Global Alcoholic Hepatitis Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Application in 2018
Figure United States Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table United States Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table United States Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table United States Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table United States Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table United States Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table United States Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Figure Europe Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table Europe Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table Europe Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Europe Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Europe Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Figure China Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table China Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table China Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table China Alcoholic Hepatitis Therapeutic Market Size by Type (2014-20189) (Million US$)
Table China Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table China Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table China Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Figure Japan Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table Japan Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table Japan Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table Japan Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Japan Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table Japan Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Japan Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Figure Southeast Asia Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Figure India Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table India Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table India Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table India Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table India Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table India Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table India Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Figure Central & South America Alcoholic Hepatitis Therapeutic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Alcoholic Hepatitis Therapeutic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Alcoholic Hepatitis Therapeutic Market Share (2018-2019)
Table Central & South America Alcoholic Hepatitis Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Central & South America Alcoholic Hepatitis Therapeutic Market Share by Type (2014-2019)
Table Central & South America Alcoholic Hepatitis Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Central & South America Alcoholic Hepatitis Therapeutic Market Share by Application (2014-2019)
Table Alkermes Company Details
Table Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019) (Million US$)
Figure Alkermes Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Alkermes Recent Development
Table Conatus pharmaceuticals Company Details
Table Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Conatus pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Conatus pharmaceuticals Recent Development
Table Dainippon sumitomo pharma Company Details
Table Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Dainippon sumitomo pharma Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Dainippon sumitomo pharma Recent Development
Table Generon corporation Company Details
Table Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Generon corporation Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Generon corporation Recent Development
Table Immuron limited Company Details
Table Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Immuron limited Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Immuron limited Recent Development
Table Lupin Laboratories Company Details
Table Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Lupin Laboratories Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Lupin Laboratories Recent Development
Table Intercept Pharmaceuticals Company Details
Table Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Intercept Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Intercept Pharmaceuticals Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2014-2019)(Million US$)
Figure Sanofi-Aventis Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2014-2019)
Table Sanofi-Aventis Recent Development
Table Global Alcoholic Hepatitis Therapeutic Market Size by Regions (Million US$) 2019-2025
Figure Global Alcoholic Hepatitis Therapeutic Market Size Share by Regions (2019-2025)
Figure Global Alcoholic Hepatitis Therapeutic Market Size Share by Regions in 2025
Figure United States Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure China Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Japan Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure India Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Alcoholic Hepatitis Therapeutic Market Size Forecast (2019-2025)(Million USD)
Table Global Alcoholic Hepatitis Therapeutic Market Size by Product (2019-2025) (Million US$)
Figure Global Alcoholic Hepatitis Therapeutic Market Size by Product (2019-2025)
Figure Global Alcoholic Hepatitis Therapeutic Market Size by Product in 2025
Table Global Alcoholic Hepatitis Therapeutic Market Size by Application (2019-2025) (Million US$)
Figure Global Alcoholic Hepatitis Therapeutic Market Size by Application (2019-2025)
Figure Global Alcoholic Hepatitis Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アルコール性肝炎治療薬の世界市場：市場規模・現状・予測 Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. The increasing consumption of alco…- 組換え治療用抗体及びタンパク質の世界市場：インサイト・予測 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…
- 肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…
- B型肝炎ウイルス（HBV）の世界市場：市場規模・現状・予測 Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…